Managing hyperthyroidism patients with unconventional therapy
- PMID: 35263056
- PMCID: PMC9991030
- DOI: 10.20945/2359-3997000000454
Managing hyperthyroidism patients with unconventional therapy
Erratum in
-
Correction: Managing hyperthyroidism patients with unconventional therapy.Arch Endocrinol Metab. 2022 Apr 28;66(2):274. doi: 10.20945/2359-3997000000470. Arch Endocrinol Metab. 2022. PMID: 35482454 Free PMC article. No abstract available.
Conflict of interest statement
Disclose: no potential conflict of interest relevant to this article was reported.
Comment on
-
Use of unconventional antithyroid therapy in patients with thiamazole agranulocytosis in the context of the COVID-19 pandemic.Arch Endocrinol Metab. 2022 Mar 8;66(1):132-133. doi: 10.20945/2359-3997000000453. Arch Endocrinol Metab. 2022. PMID: 35263055 Free PMC article. No abstract available.
References
-
- Martins JRM, Villagelin DGP, Carvalho GA, Vaisman F, Teixeira PFS, Scheffel RS, Sgarbi JA. Management of thyroid disorders during the COVID-19 outbreak: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM) Arch Endocrinol Metab . 2021 Nov 03;65(3):368–375. - PMC - PubMed
-
- Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid . 2016 Oct;26(10):1343–1421. - PubMed
-
- Ng YW, Tiu SC, Choi KL, Chan FK, Choi CH, Kong PS, Ng CM, Shek CC. Use of lithium in the treatment of thyrotoxicosis. Hong Kong Med J . 2006 Aug;12(4):254–259. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical